We are live on ! Find out more
Handelsbanken Fonder

Handelsbanken Fonder Portfolio holdings

AUM $35.1B
1-Year Est. Return 47.76%
This Fund
S&P 500
This Quarter Est. Return
+7.44%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$25.3B
AUM Growth
+$2.28B
Cap. Flow
+$944M
Cap. Flow %
3.73%
Top 10 Hldgs %
31.14%
Holding
1,538
New
18
Increased
913
Reduced
179
Closed
16

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$115M
2
BSX icon
Boston Scientific
BSX
+$76.1M
3
ATR icon
AptarGroup
ATR
+$51.5M
4
HALO icon
Halozyme
HALO
+$49.1M
5
FLNC icon
Fluence Energy
FLNC
+$37M

Top Sells

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$53.5M
2
AVGO icon
Broadcom
AVGO
+$37.8M
3
WSC icon
WillScot Mobile Mini Holdings
WSC
+$37.5M
4
TEL icon
TE Connectivity
TEL
+$26.7M
5
NVDA icon
NVIDIA
NVDA
+$23.3M

Sector Composition

Rank Sector Weight
1 Technology 34.77%
2 Healthcare 19.94%
3 Financials 10.69%
4 Industrials 8.65%
5 Communication Services 8.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SAFT icon
1376
Safety Insurance
SAFT
$1.52B
$348K ﹤0.01%
4,258
CABO icon
1377
Cable One
CABO
$191M
$347K ﹤0.01%
993
XRX icon
1378
Xerox
XRX
$412M
$343K ﹤0.01%
33,100
COHU icon
1379
Cohu
COHU
$2.66B
$342K ﹤0.01%
13,300
RCUS icon
1380
Arcus Biosciences
RCUS
$3.69B
$341K ﹤0.01%
22,300
+3,000
+16% +$47.3K
AAT
1381
American Assets Trust
AAT
$1.39B
$337K ﹤0.01%
12,602
CSGS
1382
DELISTED
CSG Systems International
CSGS
$337K ﹤0.01%
6,930
RAMP icon
1383
LiveRamp
RAMP
$2.3B
$336K ﹤0.01%
13,567
RCKT icon
1384
Rocket Pharmaceuticals
RCKT
$374M
$336K ﹤0.01%
18,200
UTZ icon
1385
Utz Brands
UTZ
$1.25B
$335K ﹤0.01%
18,900
ARI
1386
Apollo Commercial Real Estate
ARI
$885M
$334K ﹤0.01%
36,302
+5,000
+16% +$51K
CWK icon
1387
Cushman & Wakefield Ltd
CWK
$3.24B
$334K ﹤0.01%
24,500
+1,500
+7% +$18.9K
LYV icon
1388
Live Nation Entertainment
LYV
$43.2B
$334K ﹤0.01%
3,052
KW
1389
DELISTED
Kennedy-Wilson Holdings
KW
$332K ﹤0.01%
30,076
RNST icon
1390
Renasant Corp
RNST
$3.96B
$332K ﹤0.01%
10,223
WSBC icon
1391
WesBanco
WSBC
$4.07B
$331K ﹤0.01%
11,100
+1,300
+13% +$39.9K
CSIQ icon
1392
Canadian Solar
CSIQ
$1.07B
$330K ﹤0.01%
19,700
+8,100
+70% +$118K
OPRA
1393
Opera Ltd
OPRA
$1.78B
$329K ﹤0.01%
21,300
PFS icon
1394
Provident Financial Services
PFS
$3.24B
$328K ﹤0.01%
17,674
NTCT icon
1395
NETSCOUT
NTCT
$2.87B
$327K ﹤0.01%
15,032
MGNI icon
1396
Magnite
MGNI
$3.49B
$325K ﹤0.01%
23,500
GEF icon
1397
Greif
GEF
$5B
$323K ﹤0.01%
5,151
MSGE icon
1398
Madison Square Garden
MSGE
$4.18B
$323K ﹤0.01%
+7,600
New +$297K
XPEL icon
1399
XPEL
XPEL
$1.35B
$322K ﹤0.01%
7,422
+1,200
+19% +$48.4K
JBLU icon
1400
JetBlue
JBLU
$2.18B
$318K ﹤0.01%
48,400

Similar funds

Handelsbanken Fonder's Q3 2024 Portfolio in Review

As of Q3 2024, Handelsbanken Fonder held 1,538 positions worth $25.3B, up 9.9% from $23B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Handelsbanken Fonder deployed $944M of net new capital in Q3 2024, opening 18 new positions and adding to 913 existing holdings. Its largest new stake was Edison International: 24,542 shares worth $2.14M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Edwards Lifesciences, an estimated $53.5M trimmed.

  • Handelsbanken Fonder's largest Q3 2024 buy was Edison International: 24,542 shares worth $2.14M.
  • Handelsbanken Fonder added most to Merck in Q3 2024, an estimated $115M increase.
  • Handelsbanken Fonder's biggest Q3 2024 reduction was Edwards Lifesciences, cutting an estimated $53.5M.
  • Handelsbanken Fonder fully exited TE Connectivity in Q3 2024, selling an estimated $26.7M.
  • Handelsbanken Fonder's ten largest holdings make up 31% of its $25.3B portfolio in Q3 2024.
  • Handelsbanken Fonder opened 18 new positions and closed 16 in Q3 2024.
  • Handelsbanken Fonder's portfolio value rose 9.9% quarter-over-quarter to $25.3B.

Based on Handelsbanken Fonder's 13F filing for Q3 2024, filed 4 Oct 2024.